Tanvex BioPharmaTPE:6541 57 Days Inventory is 88.09 as of Dec. 2025, which is 99% below its 10-year median of 8,031.20. GuruFocus rates TPE:6541 with a GF Score™ of 57/100 and a GF Value™ of NT$255.45 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, Tanvex BioPharma ranks better than 60.97% on this metric.
The historical rank and industry rank for Tanvex BioPharma's Days Inventory or its related term are showing as below:
TPE:6541'
s Days Inventory Range Over the Past 10 Years
Min: 137.54 Med: 8031.2 Max: 118898.17
Current: 139.05
During the past 13 years, Tanvex BioPharma's highest Days Inventory was 118898.17. The lowest was 137.54. And the median was 8031.20.
TPE:6541's Days Inventory is ranked better than 60.97% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs TPE:6541: 139.05
Tanvex BioPharma's Days Inventory
declined
from Dec. 2024 (11,696.24) to Dec. 2025 (88.09).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Tanvex BioPharma's Inventory Turnover for the
three
months ended in Dec. 2025 was 1.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Tanvex BioPharma's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 2.28.
Tanvex BioPharma (TPE:6541) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Tanvex BioPharma's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Tanvex BioPharma's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Tanvex BioPharma Days Inventory Related Terms
Tanvex BioPharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Tanvex BioPharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6541 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Tanvex BioPharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tanvex BioPharma Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tanvex BioPharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Tanvex BioPharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tanvex BioPharma (TPE:6541) has a Days Inventory of 88.09 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Tanvex BioPharma and its competitors. This is 99% below median its historical median of 8,031.20. Over the past decade, Tanvex BioPharma's Days Inventory has ranged from 137.54 to 118,898.17. According to the industry distribution chart, Tanvex BioPharma ranks #249 out of 638 companies in the Biotechnology industry, placing it in the top 39%.
Is Tanvex BioPharma's Days Inventory too high?
Tanvex BioPharma's current Days Inventory of 88.09 is 99% below median its 10-year median of 8,031.20. Over the past 10 years, this metric has ranged from a low of 137.54 to a high of 118,898.17. The Biotechnology industry median Days Inventory is 183.20. Tanvex BioPharma's value of 88.09 is 51.9% below this industry median. Based on the distribution chart, Tanvex BioPharma ranks #249 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Tanvex BioPharma has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tanvex BioPharma's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tanvex BioPharma ranks #249 out of 638 companies for Days Inventory. This puts Tanvex BioPharma in the upper half of its industry. The industry median Days Inventory is 183.20. Tanvex BioPharma's value of 88.09 is 51.9% below this benchmark. Historically, Tanvex BioPharma's own Days Inventory has ranged from 137.54 to 118,898.17 over the past decade. While the company's 10-year median is 8,031.20 vs. the industry median of 183.20, Tanvex BioPharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tanvex BioPharma's current Days Inventory of 88.09 is 51.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Tanvex BioPharma and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tanvex BioPharma's current Days Inventory is 88.09, which is 99% below median its own 10-year median of 8,031.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tanvex BioPharma stock overvalued right now?
Based on GuruFocus' analysis, Tanvex BioPharma (TPE:6541) is currently considered Possible Value Trap. The stock's GF Value™ is NT$255.45, compared to a current price of NT$40.80 — trading 84% below its estimated fair value. The current Days Inventory is 88.09, which is 99% below median its 10-year median of 8,031.20 and 51.9% below the Biotechnology industry median of 183.20. Tanvex BioPharma's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Tanvex BioPharma (TPE:6541), the current Days Inventory is 88.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tanvex BioPharma (TPE:6541) Overvalued in 2026?
Based on GuruFocus' analysis, Tanvex BioPharma stock appears to be undervalued.
The current stock price of NT$40.80 is trading 84% below its estimated GF Value™ of NT$255.45.
GuruFocus considers Tanvex BioPharma to be Possible Value Trap.
Key valuation signals for TPE:6541:
Days Inventory: 88.09 (99% below median its 10-year median of 8,031.20)
GF Value™: NT$255.45 vs. price of NT$40.80 (84% below fair value)
Industry Position: 51.9% below the Biotechnology median (#249 of 638)
No single metric tells the full story. See the TPE:6541 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products and contract development and manufacturing of biological medicine. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others. Geographically, the company operates in Asia, America, Europe, and Australia. The company generates a majority of its revenue from the USA.
57GF Score
Get the complete analysis for TPE:6541
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6541 has been successfully added to your 
